PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly EBT Margin came in at 38.11% in Q1 2026, down 227.0% year-on-year from 30.01% in Q1 2025, and up 10.83% on a QoQ basis from 42.74% in Q4 2025.
PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 7 years of EBT Margin data on file, last reported at 38.11% in Q1 2026.
- On a quarterly basis, EBT Margin fell 227.0% year-over-year to 38.11% in Q1 2026; TTM through Mar 2026 was 57.73%, a 1271.0% decrease from a year earlier, with the FY2025 full-year figure at 30.96%, up 959.0% from the prior year.
- EBT Margin for Q1 2026 stood at 38.11%, up from 42.74% in the prior quarter.
- Over the last five years, EBT Margin for PRCT reached as high as 30.29% in Q4 2024 and fell as low as 319.44% in Q1 2023.
- Historically, EBT Margin has averaged 98.05% across 5 years, with a median of 76.81% in 2025.
- Across the five-year window, EBT Margin tumbled 18111 bps in 2023 and soared 22617 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 100.82% in 2022, then surged by 30 bps to 70.4% in 2023, then soared by 57 bps to 30.29% in 2024, then plunged by 41 bps to 42.74% in 2025, then advanced by 11 bps to 38.11% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 38.11% in Q1 2026, 42.74% in Q4 2025, and 72.9% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 22.61% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 9.84% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 4.87% |
| 10 | PROCEPT BioRobotics | 1.03 Bn | 779.47 Mn | 53.95 Mn | -38.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.11% |
| Dec 31, 2025 | -42.74% |
| Sep 30, 2025 | -72.90% |
| Jun 30, 2025 | -76.81% |
| Mar 31, 2025 | -35.83% |
| Dec 31, 2024 | -30.29% |
| Sep 30, 2024 | -60.05% |
| Jun 30, 2024 | -59.30% |
| Mar 31, 2024 | -93.27% |
| Dec 31, 2023 | -70.40% |
| Sep 30, 2023 | -85.56% |
| Jun 30, 2023 | -133.05% |
| Mar 31, 2023 | -319.44% |
| Dec 31, 2022 | -100.82% |
| Sep 30, 2022 | -194.30% |
| Jun 30, 2022 | -115.73% |
| Mar 31, 2022 | -138.32% |
| Dec 31, 2021 | -180.22% |
| Sep 30, 2021 | -206.95% |
| Jun 30, 2021 | -172.58% |